A recent recommendation for COVID-19 patients to undergo a neuro MR exam prompted
"There's no doubt that COVID-19 has impacted all of us in significant ways," explains
While most are aware of respiratory affects, COVID-19 patients are also at risk for long-term neuropsychiatric and neurocognitive conditions, including depression, OCD, psychosis, Parkinson's, and Alzheimer's. A baseline MRI exam is critical to understanding and promoting continued care in patients. In addition, neurological complications can occur after COVID-19 infection, but it's still not clear if this is from the virus, the body's response, or the formation of clots.
"The last thing any doctor or patient want is another lengthy procedure when they're trying to discharge," continues Frye. "Our SyMRI software is a natural solution, providing a quick 5-6-minute scan that delivers 8 different contrast-weighted images that are fully adjustable for any combination of TE, TR, and T1; which means patient call back can be reduced."
The software also provides segmentation and volume estimation of different tissue types (CSF,
"Our goal is simple: we want to provide the best solutions to doctors so they can do their job in saving lives," adds Frye. "That's never changed. But if we can help remove some obstacles for patients and radiologists and help foster understanding, we all win."
For more information on how physicians and/or facilities can qualify for access to SyMRI software, please contact (859) 512-9496 or info.us@syntheticmr.com.
https://news.cision.com/syntheticmr-ab/r/now-facilities-can-access-cutting-edge-neuro-mr-capabilities-to-comply-with-new-covid-19-recommendat,c3153871
https://mb.cision.com/Main/11663/3153871/1279030.pdf
(c) 2020 Cision. All rights reserved., source